Skip to main content

Baylor to Sequence More than 5,000 Exomes for Human Disease Studies


The Human Genome Sequencing Center at Baylor College of Medicine plans to use Roche NimbleGen exome capture products as part of an effort to sequence more than 5,000 human exomes over the next two years to discover genetic variants underlying a number of human diseases, the company said this week.

Funded by the National Institutes of Health and several research consortia, Baylor researchers plan to study more than 15 diseases by exome sequencing, including cancer of the brain, liver, pancreas, colon, ovary, and bladder; heart disease; diabetes; autism; and several inherited diseases.

The center will use both NimbleGen's SeqCap EZ Exome and customized NimbleGen exome designs in these studies, according to the company. In collaboration with Roche NimbleGen, it has established a pipeline for high-throughput exome capture and sequencing “with multiple next-generation sequencing platforms.”

Baylor has already sequenced the exomes of approximately 1,000 samples, and captured and sequenced DNA from about 1,000 additional samples, according to NimbleGen.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.